Tongji School of Pharmacy;
Huazhong University of Science and Technology;
Department of Pharmacy;
the Third Hospital of Wuhan;
Centre for Biomedicine Research;
Wuhan Institutes of Biotechnology;
glucagon-like peptide-1 receptor(GLP-1R); GLP-1R agonists; type 2 diabetes;